Security key
28176E108
Edwards Lifesciences Corp - Common Stock (EW)
CUSIP: 28176E108
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 502,121,728
- Total 13F value
- $37,169,453,852
- Share change
- +18,345,423
- Put/Call ratio
- 46%
- SEC-reported price per share
- $74.03
- Number of holders
- 1,216
- Value change
- +$1,434,005,846
- Number of buys
- 453
- Number of sells
- 627
- Shares outstanding
- 576,625,106
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
1,216
Top holders
10
EW full security history
Ownership snapshot
Full 13F holder table
Edwards Lifesciences Corp SEC filings
Edwards Lifesciences Corp company facts
Broader feeds
Ownership snapshot
Top reported holders of EW - Edwards Lifesciences Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
30 Sep 2024
13F
Highest disclosed value: $4,130,613,827
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $4.13B.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
VANGUARD GROUP INC
$4.13B
BlackRock, Inc.
$3.6B
WELLINGTON MANAGEMENT GROUP LLP
$2.08B
STATE STREET CORP
$1.73B
Bank of New York Mellon Corp
$1.21B
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$4,130,613,827
62,594,542 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
—
denominator unverified
|
$3,602,075,082
54,585,166 shares
|
— | 30 Sep 2024 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
—
denominator unverified
|
$2,080,844,522
31,532,725 shares
|
— | 30 Sep 2024 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$1,733,269,528
26,265,633 shares
|
— | 30 Sep 2024 |
| Bank of New York Mellon Corp |
13F
Company
|
—
denominator unverified
|
$1,208,034,239
18,306,323 shares
|
— | 30 Sep 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$889,049,964
13,521,147 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1,216
Shares
502,121,728
Rows available
1,216
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
1,173
Q4 2024 holders
1,216
Holder diff
43
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|